A lokális recidíva okai a végbélrák radikális mûtétei után.

Translated title of the contribution: Causes of local recurrence after curative surgery for rectal cancer

József Hôhn, László Varga, Gellért Baradnay, Zsolt Simonka, Tibor Géczi, Ferenc Nagy, Tamás Molnár, Anikó Maráz, Zsuzsa Kahán, Adám Balogh

Research output: Contribution to journalArticle

Abstract

The rate of local recurrence (LR) has been 20-40% after resective surgery for rectal cancer by the traditional - Miles or Dixon - operative technics. The authors performed curative resection in 358 patients with rectal cancer in a 10 year period (01.01.1990 - 31.12.2000) in the Surgical Department of Szeged University. Since 01.01.1996 the authors changed this type of surgery for the Heald technics (total mesorectal excision - TME - with sharp dissection, using the UltraCision device) for the surgical treatment of middle or lower third rectal cancer. To compare the results of the two procedures, the authors analysed their material in two periods: Period I: 01.01.1991 - 31.12.1992: 62 patients operated on with the traditional operative technics; LR 15% within 2 years after surgery. Period II: 01.01.1997 - 31.12.1998: 78 patients operated on with the Heald technics (TME with sharp dissection); LR 6.4% within 2 years after surgery. Based on their results, the authors found that the modern operative technics by Heald, used in the second period of the study, was a relevant factor decreasing LR from 15% to 6.4%, while the gender, age of the patients, ratio of the abdominoperineal extirpation versus anterior resection (APRE/AR) and the free margin of more than 3 cm proved to be irrelevant.

Original languageHungarian
Pages (from-to)355-359
Number of pages5
JournalMagyar Onkologia
Volume47
Issue number4
Publication statusPublished - 2003

Fingerprint

Rectal Neoplasms
Recurrence
Dissection
Equipment and Supplies
Therapeutics

ASJC Scopus subject areas

  • Cancer Research

Cite this

Hôhn, J., Varga, L., Baradnay, G., Simonka, Z., Géczi, T., Nagy, F., ... Balogh, A. (2003). A lokális recidíva okai a végbélrák radikális mûtétei után. Magyar Onkologia, 47(4), 355-359.

A lokális recidíva okai a végbélrák radikális mûtétei után. / Hôhn, József; Varga, László; Baradnay, Gellért; Simonka, Zsolt; Géczi, Tibor; Nagy, Ferenc; Molnár, Tamás; Maráz, Anikó; Kahán, Zsuzsa; Balogh, Adám.

In: Magyar Onkologia, Vol. 47, No. 4, 2003, p. 355-359.

Research output: Contribution to journalArticle

Hôhn, J, Varga, L, Baradnay, G, Simonka, Z, Géczi, T, Nagy, F, Molnár, T, Maráz, A, Kahán, Z & Balogh, A 2003, 'A lokális recidíva okai a végbélrák radikális mûtétei után.', Magyar Onkologia, vol. 47, no. 4, pp. 355-359.
Hôhn J, Varga L, Baradnay G, Simonka Z, Géczi T, Nagy F et al. A lokális recidíva okai a végbélrák radikális mûtétei után. Magyar Onkologia. 2003;47(4):355-359.
Hôhn, József ; Varga, László ; Baradnay, Gellért ; Simonka, Zsolt ; Géczi, Tibor ; Nagy, Ferenc ; Molnár, Tamás ; Maráz, Anikó ; Kahán, Zsuzsa ; Balogh, Adám. / A lokális recidíva okai a végbélrák radikális mûtétei után. In: Magyar Onkologia. 2003 ; Vol. 47, No. 4. pp. 355-359.
@article{7a02a9a4da424ceaa5ab13ce08fc0a6d,
title = "A lok{\'a}lis recid{\'i}va okai a v{\'e}gb{\'e}lr{\'a}k radik{\'a}lis m{\^u}t{\'e}tei ut{\'a}n.",
abstract = "The rate of local recurrence (LR) has been 20-40{\%} after resective surgery for rectal cancer by the traditional - Miles or Dixon - operative technics. The authors performed curative resection in 358 patients with rectal cancer in a 10 year period (01.01.1990 - 31.12.2000) in the Surgical Department of Szeged University. Since 01.01.1996 the authors changed this type of surgery for the Heald technics (total mesorectal excision - TME - with sharp dissection, using the UltraCision device) for the surgical treatment of middle or lower third rectal cancer. To compare the results of the two procedures, the authors analysed their material in two periods: Period I: 01.01.1991 - 31.12.1992: 62 patients operated on with the traditional operative technics; LR 15{\%} within 2 years after surgery. Period II: 01.01.1997 - 31.12.1998: 78 patients operated on with the Heald technics (TME with sharp dissection); LR 6.4{\%} within 2 years after surgery. Based on their results, the authors found that the modern operative technics by Heald, used in the second period of the study, was a relevant factor decreasing LR from 15{\%} to 6.4{\%}, while the gender, age of the patients, ratio of the abdominoperineal extirpation versus anterior resection (APRE/AR) and the free margin of more than 3 cm proved to be irrelevant.",
author = "J{\'o}zsef H{\^o}hn and L{\'a}szl{\'o} Varga and Gell{\'e}rt Baradnay and Zsolt Simonka and Tibor G{\'e}czi and Ferenc Nagy and Tam{\'a}s Moln{\'a}r and Anik{\'o} Mar{\'a}z and Zsuzsa Kah{\'a}n and Ad{\'a}m Balogh",
year = "2003",
language = "Hungarian",
volume = "47",
pages = "355--359",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "4",

}

TY - JOUR

T1 - A lokális recidíva okai a végbélrák radikális mûtétei után.

AU - Hôhn, József

AU - Varga, László

AU - Baradnay, Gellért

AU - Simonka, Zsolt

AU - Géczi, Tibor

AU - Nagy, Ferenc

AU - Molnár, Tamás

AU - Maráz, Anikó

AU - Kahán, Zsuzsa

AU - Balogh, Adám

PY - 2003

Y1 - 2003

N2 - The rate of local recurrence (LR) has been 20-40% after resective surgery for rectal cancer by the traditional - Miles or Dixon - operative technics. The authors performed curative resection in 358 patients with rectal cancer in a 10 year period (01.01.1990 - 31.12.2000) in the Surgical Department of Szeged University. Since 01.01.1996 the authors changed this type of surgery for the Heald technics (total mesorectal excision - TME - with sharp dissection, using the UltraCision device) for the surgical treatment of middle or lower third rectal cancer. To compare the results of the two procedures, the authors analysed their material in two periods: Period I: 01.01.1991 - 31.12.1992: 62 patients operated on with the traditional operative technics; LR 15% within 2 years after surgery. Period II: 01.01.1997 - 31.12.1998: 78 patients operated on with the Heald technics (TME with sharp dissection); LR 6.4% within 2 years after surgery. Based on their results, the authors found that the modern operative technics by Heald, used in the second period of the study, was a relevant factor decreasing LR from 15% to 6.4%, while the gender, age of the patients, ratio of the abdominoperineal extirpation versus anterior resection (APRE/AR) and the free margin of more than 3 cm proved to be irrelevant.

AB - The rate of local recurrence (LR) has been 20-40% after resective surgery for rectal cancer by the traditional - Miles or Dixon - operative technics. The authors performed curative resection in 358 patients with rectal cancer in a 10 year period (01.01.1990 - 31.12.2000) in the Surgical Department of Szeged University. Since 01.01.1996 the authors changed this type of surgery for the Heald technics (total mesorectal excision - TME - with sharp dissection, using the UltraCision device) for the surgical treatment of middle or lower third rectal cancer. To compare the results of the two procedures, the authors analysed their material in two periods: Period I: 01.01.1991 - 31.12.1992: 62 patients operated on with the traditional operative technics; LR 15% within 2 years after surgery. Period II: 01.01.1997 - 31.12.1998: 78 patients operated on with the Heald technics (TME with sharp dissection); LR 6.4% within 2 years after surgery. Based on their results, the authors found that the modern operative technics by Heald, used in the second period of the study, was a relevant factor decreasing LR from 15% to 6.4%, while the gender, age of the patients, ratio of the abdominoperineal extirpation versus anterior resection (APRE/AR) and the free margin of more than 3 cm proved to be irrelevant.

UR - http://www.scopus.com/inward/record.url?scp=1542714908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542714908&partnerID=8YFLogxK

M3 - Article

C2 - 14716430

VL - 47

SP - 355

EP - 359

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 4

ER -